Sign in

CIK 0001664710

  • Non-accelerated filer
  • Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
811173868
Phone
+1 617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,619
in 1 filing, $6K under 10b5-1 plans

Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Prener Anne −$6K Director sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion +2,650 $0.30 $795 88,350
2022-03-11 Lachey Jennifer Chief Scientific Officer Sale −1,062 $52.43 $56K 87,288
2022-03-11 Lachey Jennifer Chief Scientific Officer Sale −713 $53.36 $38K 86,575
2022-03-11 Lachey Jennifer Chief Scientific Officer Sale −875 $54.54 $48K 85,700
2022-03-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −2,650 84,655
2022-02-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion +2,650 $0.30 $795 88,350
2022-02-11 Lachey Jennifer Chief Scientific Officer Sale −1,073 $51.50 $55K 87,277
2022-02-11 Lachey Jennifer Chief Scientific Officer Sale −1,378 $52.35 $72K 85,899
2022-02-11 Lachey Jennifer Chief Scientific Officer Sale −199 $53.10 $11K 85,700
2022-02-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −2,650 87,305
2022-02-01 Rovaldi Christopher Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2022-01-21 Seehra Jasbir Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +165,000 165,000
2022-01-21 Regnante Keith Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2022-01-21 Lachey Jennifer Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2022-01-21 Cooper Simon Peter Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2022-01-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion +2,650 $0.30 $795 88,350
2022-01-11 Lachey Jennifer Chief Scientific Officer Sale −320 $52.01 $17K 88,030
2022-01-11 Lachey Jennifer Chief Scientific Officer Sale −1,196 $53.56 $64K 86,834
2022-01-11 Lachey Jennifer Chief Scientific Officer Sale −1,134 $54.45 $62K 85,700
2022-01-11 Lachey Jennifer Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −2,650 89,955

Page 11 of 36 · 707 trades